Why It Matters

Albertsons faces a convergence of regulatory and market pressures threatening its business model. Organized retail crime is causing measurable financial losses and store safety concerns. Pharmacy reimbursement rates face federal scrutiny amid litigation against major PBMs. Grocery pricing has become a political flashpoint, inviting legislative proposals to regulate retailer pricing practices. Meanwhile, credit card interchange fees continue eroding merchant margins.

Albertsons’ lobbying investment in the third quarter reflects the stakes: the company is pushing for federal action on retail crime prevention, PBM reform, and merchant protections on payment processing. Success means shaping policy before Congress imposes stricter antitrust enforcement or consumer-focused regulations. Failure could mean higher losses from theft, compressed pharmacy margins, and constrained pricing flexibility.

By the Numbers

Albertsons Companies, Inc. spent $740,000 on in-house lobbying in this quarter part of approximately $14.05 million in cumulative expenditures across 81 total lobbying disclosures since 2018.

In-house operations dominate Albertsons’ lobbying approach, accounting for $9.96 million across 18 filings since August 2021. The company supplements this with specialized external firms: Cogent Strategies LLC ($1.65 million since January 2022) focuses on pharmacy legislation and organized retail crime, while Ballard Spahr LLP ($1.12 million since April 2021) handles competition and antitrust matters.

This represents routine ongoing advocacy, not a strategic shift. Albertsons maintains consistent spending levels and lobbying focus across quarters, prioritizing pharmacy benefit manager reform, organized retail crime legislation, food policy, labor issues, and grocery competition—core concerns since 2018.

The Agenda

Albertsons Companies, Inc. is lobbying on issues critical to its grocery and pharmacy operations, with primary focus on combating organized retail crime, reforming pharmacy benefit managers, addressing food pricing, managing labor issues, and navigating grocery competition.

The company is actively supporting the bipartisan Combating Organized Retail Crime Act and its House companion, H.R. 2853, which would establish a federal coordination center and enhance law enforcement tools. On pharmacy issues, Albertsons is lobbying for the PBM Reform Act of 2025 and Senate’s Patients Before Middlemen Act to increase drug pricing transparency and ensure fair pharmacy reimbursement.

The company is also tracking food access legislation, including the Stop Price Gouging in Grocery Stores Act and payment processing reform addressing credit card interchange fees.

Broader Context

Congress is actively addressing policy issues that directly impact Albertsons‘s operations. Retailers face an 18% increase in shoplifting incidents and 17% rise in theft-related violence, with the bipartisan Combating Organized Retail Crime Act gaining strong momentum.

Food prices have surged 29% since February 2020, making grocery price inflation politically toxic. Congress is scrutinizing retail competition through multiple bills targeting price gouging and food deserts, creating regulatory uncertainty for major operators.

Pharmacy Benefit Manager reform is accelerating through federal litigation and bipartisan congressional efforts. The PBM Reform Act and Patients Before Middlemen Act could reshape reimbursement structures for Albertsons‘s pharmacy division.

The failed Kroger merger heightened antitrust scrutiny, with the December 2024 court block underscoring intensified FTC focus on retail consolidation.

Between The Lines

The Combating Organized Retail Crime Act and its House companion—which Albertsons is specifically lobbying on—enjoy strong bipartisan support from Senators Chuck Grassley (R-IA) and Catherine Cortez Masto (D-NV), plus House members Susie Lee (D-NV) and Dave Joyce (R-OH).

On pharmacy issues, Albertsons has previously lobbied on multiple PBM-related bills including the Pharmacy Benefit Manager Transparency Act.

Congress is examining grocery market competition through the Stop Price Gouging in Grocery Stores Act, which would give the FTC authority to prohibit excessive pricing. Food access bills include the Food Deserts Act and Healthy Food Access for All Americans Act.

Competitive Landscape

Albertsons isn’t alone in pushing federal action on these priorities. Walmart Inc. and Wakefern Food Corp. are actively lobbying on identical issues.

Both retailers have lobbied in support of the Combating Organized Retail Crime Act, reflecting industry-wide theft concerns. Walmart has also advocated for the Credit Card Competition Act and lobbied on pharmacy access and reimbursement bills.

This alignment demonstrates that organized retail crime, payment processing reform, and pharmacy regulation are industry-level challenges requiring federal solutions—not company-specific concerns.

The Bottom Line

Albertsons is focussing on organized retail crime, pharmacy benefit manager reform, food pricing, and payment processing fees—all areas where Congress is actively legislating.

The Combating Organized Retail Crime Act enjoys bipartisan momentum and has become a top priority. Multiple bills addressing PBM reform, grocery pricing, and food access are advancing, creating complex legislative landscape. Albertsons’ spending aligns with broader industry trends, where competitors face identical policy challenges. The significant investment reflects genuine uncertainty facing major retailers on multiple fronts simultaneously.

Spot something wrong? Report an issue with this article